ADVISORY/Experts Available To Discuss Plant-derived Pharmaceuticals and HIV Treatment.Business Editors ADVISORY... --(BUSINESS WIRE)--Jan. 29, 2003 TOPIC: Epicyte Pharmaceutical Inc. is a privately held company that is working on a preventive treatment for HIV through the use of plant-derived pharmaceuticals, according to an article by the San Diego Daily Transcript. The biopharmaceutical company plans to produce human antibodies in corn. Experts say using corn, soy and certain aquatic plants can bring forth more proteins than cultured animal cells at less cost. Epicyte officials claim these antibodies will strengthen the immune system, thus making the system more resistant to the HIV virus, the article says. EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story: Kevin Whaley is the director of antibody discovery with Epicyte. He joined Epicyte in October of 1999, after spending the previous 15 years at Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. and ReProtect, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control ., developing microbicides that prevent pregnancy and sexually transmitted disease sexually transmitted disease (STD) or venereal disease, term for infections acquired mainly through sexual contact. Five diseases were traditionally known as venereal diseases: gonorrhea, syphilis, and the less common granuloma inguinale, . Dr. Whaley received his Ph.D. in 1984 from the Medical College of Ohio and in 1998, co-founded the Alliance for Microbicide Development, an organization that unites corporate, academic, and advocacy institutions in the rapid development of vaginal microbicides. Dr. Whaley is Project Leader of a 5-year NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. funded program to develop antibody-based microbicides and is Principal Investigator on several NIH SBIR SBIR Small Business Innovation Research (program/grant) SBIR Space Based Infra-Red SBIR Speaker-Boundary Interference SBIR Site Backsurface-referenced Ideal Plane/Range (silicon wafers) grants for the preclinical and clinical evaluation of Epicyte's PlantibodiesT products. PR: Rick Cook, 619/283-4322, rcook@gcs-pr.com Professor John Alexander Thomas Young, of Harvard University, Medical School Department of Microbiology and Molecular Genetics, is an expert regarding HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. , virology and biotechnology. 617-432-1543, 617-495-1000 (University PR Phone) Professor Daniel Azarnoff, of the University of Kansas The University of Kansas (often referred to as KU or just Kansas) is an institution of higher learning in Lawrence, Kansas. The main campus resides atop Mount Oread. , can share his expertise on topics including biopharmaceutics. 785-864-2700 (University PR Phone) ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue. ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/ifmd/index.html. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion